Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty

Phase 4TerminatedNCT02933671

Duke University11 enrolled

Overview

The purpose of this study is to learn if using a suprainguinal fascia iliaca (SIFI) injection technique (also called a "nerve block") that numbs the nerves going to the side and front of the upper leg will improve pain control after surgery. The SIFI technique uses a numbing solution (local anesthetics) that is injected next to nerves in the hip to reduce pain. This block may affect movement in the leg and make the legs weak. The amount of leg weakness is not known and assessment of this will be included in the study. Many institutions use the SIFI block for patients having total hip replacements, with the hope of providing good pain relief combined with improved mobility after surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Enrollment

Conditions

Hip Osteoarthritis Primary Total Hip Arthroplasty Pain

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * English speaking * between 18 and 75 years old * American Society of Anesthesiologists (ASA) 1-3 patients undergoing primary total hip arthroplasty Exclusion Criteria: * ASA 4 or 5 * revision hip arthroplasty * diagnosis of chronic pain * daily chronic opioid use (over 3 months of continuous opioid use) * inability to communicate pain scores or need for analgesia * acute hip fracture * Infection at the site of block placement * Age under 18 years old or greater than 75 years old * Pregnant women * Intolerance/allergy to local anesthetics * Weight \<50 kg * Suspected, or known addiction to or abuse of illicit drug(s), prescription medicine(s), or alcohol within the past 2 years. * Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the opinion of the investigator, may interfere with study assessments or compliance * Current or historical evidence of any clinically significant disease or condition that, in the opinion of the investigator, may increase the risk of surgery or complicate the subject's postoperative course.

Outcomes

Primary Outcomes

Numeric Pain Score at 4 Hours Postoperatively, as Measured by Numerical Rating Scale (NRS) 11

The NRS 11 ranges from 0 (no pain) to 10 (intense pain).

Time frame: 4 hours postoperatively

Secondary Outcomes

Cumulative Opioid Consumption

Reported in IV morphine equivalents.

Time frame: 24 hours

Motor Strength, as Measured by Dynamometry

Reported as pounds per square inch (PSI).